ACRS
Aclaris Therapeutics, Inc.
$5.60
+0.17 (+3.13%)
At close · Jul 15
Market Cap
$748.60M
Shares
139,663,680
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Capacity | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2025-02-27 | — | — | 2026-03-31 | — | 10-Q , filed 2026-05-07 |